# Single-incision laparoscopic partial splenectomy for benign pediatric splenic tumors: a retrospective comparative study

**Authors:** Ran Tang, De-Cheng Wei, Cheng-Xiao Zhou, Zhong-Ce Li, Jian Bian, Shi-Qin Qi

PMC · DOI: 10.3389/fped.2025.1633940 · Frontiers in Pediatrics · 2025-07-22

## TL;DR

This study shows that single-incision laparoscopic partial splenectomy is a safe option for children with benign spleen tumors, with fewer blood-related complications.

## Contribution

Demonstrates the safety and effectiveness of single-incision laparoscopic partial splenectomy in pediatric patients with benign splenic tumors.

## Key findings

- SILPS had comparable operative time, blood loss, and hospital stay to total splenectomy.
- SILPS resulted in significantly lower postoperative thrombocytosis and leukocytosis.
- No major complications were observed in the SILPS group.

## Abstract

The indications for laparoscopic partial splenectomy (LPS) in pediatric benign splenic tumors are well established, but concerns remain regarding its technical complexity and potential complications. This study aimed to evaluate the safety and outcomes of single-incision LPS (SILPS).

A retrospective analysis was conducted on 22 children who underwent SILPS from July 2021 to April 2024, compared with 25 patients who received laparoscopic total splenectomy (TS). Clinical characteristics, operative details, and postoperative outcomes were assessed.

SILPS patients had comparable operative time, blood loss, and hospital stay to those in the TS group. However, SILPS was associated with significantly lower rates of postoperative thrombocytosis and leukocytosis. No major perioperative complications were observed.

SILPS is a safe and effective spleen-preserving technique for pediatric benign splenic tumors, offering reduced hematologic complications without increasing surgical risks. It is technically demanding and requires experienced laparoscopic skills and proper patient selection.

## Full-text entities

- **Diseases:** fever (MESH:D005334), splenomegaly (MESH:D013163), leukocytosis (MESH:D007964), thromboembolic complications (MESH:D013923), thalassemia (MESH:D013789), blood (MESH:D006402), infection (MESH:D007239), Benign tumors (MESH:D009369), Abnormal coagulation function (MESH:D001778), pulmonary hypertension (MESH:D006976), abscess (MESH:D000038), intra-abdominal hemorrhage (MESH:D000082122), sepsis (MESH:D018805), PVT (MESH:D012170), pulmonary infection (MESH:D012141), hypercoagulability (MESH:D019851), splenic infarction (MESH:D013159), splenic cysts (MESH:D003560), portal phlebitis (MESH:D010689), splenic rupture (MESH:D013161), thrombocytosis (MESH:D013922), thrombosis (MESH:D013927), bleeding (MESH:D006470), OPSI (MESH:D000094025), ischemia (MESH:D007511), benign splenic tumor (MESH:D013160), trauma (MESH:D014947), TS (MESH:C535338), blood loss (MESH:D016063), ischemic (MESH:D002545), intra-abdominal abscesses (MESH:D018784), splenic disease (MESH:D013158), CL (MESH:D002971), splenic lymphangioma (MESH:D008202), HS (MESH:D013103)
- **Chemicals:** Carbon dioxide (MESH:D002245), PS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12321813/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12321813/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12321813/full.md

---
Source: https://tomesphere.com/paper/PMC12321813